Doximity, Inc. (DOCS) stock
DOCSNYSEServices-Computer Programming ServicesFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3022% above fair value
$33.22+0.80 (+2.47%)
Close on Nov 11, 2026Market cap $5.92BP/E 46.1Yield –
Doximity EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Doximity's EPS for the twelve months ending Sep 30, 2026 was $0.72, down 42.9% year over year. For fiscal 2026 it was $0.98, down 11.7% from the year before. The highest annual figure on record is $1.11 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $0.98 | -11.7% |
| FY2025 | Mar 31, 2025 | $1.11 | +54.2% |
| FY2024 | Mar 31, 2024 | $0.72 | +35.8% |
| FY2023 | Mar 31, 2023 | $0.53 | -24.3% |
| FY2022 | Mar 31, 2022 | $0.70 | +204.3% |
| FY2021 | Mar 31, 2021 | $0.23 | +76.9% |
| FY2020 | Mar 31, 2020 | $0.13 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ3 2026 | Sep 30, 2026 | $0.18 | -41.9% |
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $0.13 | -51.9% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $0.10 | -67.7% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $0.31 | -16.2% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $0.31 | +40.9% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $0.27 | +28.6% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $0.31 | +55.0% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $0.37 | +54.2% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $0.22 | +46.7% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $0.21 | +61.5% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $0.20 | +42.9% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $0.24 | +50.0% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $0.15 | +25.0% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $0.13 | +30.0% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $0.14 | -17.6% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $0.16 | -38.5% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $0.12 | -29.4% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $0.10 | +11.1% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $0.17 | +70.0% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $0.26 | +420.0% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $0.17 | +750.0% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $0.09 | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $0.10 | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $0.05 | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $0.02 | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $0.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?